Clinical trial
Pilot Study to Assess Heterogeneity of the Blood Brain Barrier in Patients with CNS Malignancy
NCT03071913 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study to Assess Heterogeneity of the Blood Brain Barrier in Patients with CNS Malignancy
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 20, 2017
- Completion date
- January 12, 2023
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
central nervous system neoplasm, localized brain neoplasm, metastatic malignant neoplasm in the brain, recurrent brain neoplasm